News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
265,108 Results
Type
Article (23031)
Company Profile (80)
Press Release (241983)
Multimedia
Podcasts (66)
Webinars (3)
Section
Business (72333)
Career Advice (205)
Deals (10973)
Drug Delivery (54)
Drug Development (46730)
Employer Resources (17)
FDA (6214)
Job Trends (4774)
News (124682)
Policy (10224)
Tag
2027 BioCapital Standard (2)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Standard (2)
2027 Genetown Standard (2)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (3)
Academia (1338)
Academic (1)
Accelerated approval (50)
ADA (16)
Adcomms (17)
Allergies (68)
Alliances (21016)
ALS (155)
Alzheimer's disease (824)
Antibody-drug conjugate (ADC) (552)
Approvals (6600)
Artificial intelligence (286)
ASCO (271)
Autoimmune disease (347)
Automation (36)
Bankruptcy (50)
Belgium (1)
Best Places to Work (4179)
BIO (35)
Biologics (10)
BIOSECURE Act (6)
Biosimilars (160)
BioSpace Insights (49)
Biotechnology (71)
Bispecific (2)
Bladder cancer (167)
Brain cancer (59)
Breast cancer (568)
Cancer (5454)
Cardiovascular disease (164)
Career advice (183)
Career pathing (7)
CAR-T (409)
CDC (7)
CDMO (99)
Celiac Disease (1)
Cell therapy (1135)
Cervical cancer (34)
Clinical research (40394)
Collaboration (1366)
Commercialization (4)
Company closure (4)
Compensation (423)
Complete response letters (47)
COVID-19 (1251)
CRISPR (102)
C-suite (587)
Cystic fibrosis (99)
Data (5641)
Denatured (13)
Depression (34)
Dermatology (59)
Diabetes (281)
Diagnostics (2424)
Digital health (13)
Diversity (2)
Diversity, equity & inclusion (4)
Drug discovery (224)
Drug pricing (29)
Drug shortages (2)
Duchenne muscular dystrophy (186)
Earnings (24970)
Editorial (20)
Employer branding (2)
Employer resources (18)
Events (40178)
Executive appointments (413)
FDA (8382)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (10)
Frontotemporal dementia (18)
Funding (912)
Gene editing (204)
Generative AI (25)
Gene therapy (644)
GLP-1 (309)
Government (1251)
Grass and pollen (2)
Guidances (149)
Healthcare (6039)
Hematology (162)
HIV (46)
Huntington's disease (26)
IgA nephropathy (76)
Immunology and inflammation (204)
Immuno-oncology (118)
Indications (138)
Infectious disease (1395)
Inflammatory bowel disease (116)
Inflation Reduction Act (5)
Influenza (54)
Intellectual property (154)
Interviews (41)
IPO (5052)
IRA (5)
Job creations (793)
Job search strategy (146)
JPM (33)
Kidney cancer (28)
Kidney disease (43)
Labor market (12)
Layoffs (206)
Leadership (8)
Legal (1689)
Licensing (15)
Liver cancer (76)
Longevity (23)
Lung cancer (933)
Lymphoma (499)
Machine learning (34)
Management (5)
Manufacturing (725)
Marketing (6)
MASH (60)
Medical device (2300)
Medtech (2342)
Mergers & acquisitions (6484)
Metabolic disorders (537)
mRNA (159)
Multiple sclerosis (150)
Multispecific (1)
NASH (4)
Netherlands (1)
Neurodegenerative disease (233)
Neuropsychiatric disorders (18)
Neuroscience (1596)
NextGen: Class of 2026 (1631)
Non-profit (982)
Now hiring (17)
Obesity (190)
Opinion (100)
Ovarian cancer (219)
Pain (72)
Pancreatic cancer (238)
Parkinson's disease (214)
Partnered (18)
Patents (328)
Patient recruitment (493)
Patient selection (5)
Peanut (18)
People (18239)
Peptides (6)
Pharmaceutical (11)
Pharmacy benefit managers (5)
Phase 1 (14805)
Phase 2 (18212)
Phase 3 (12283)
Pipeline (6155)
Policy (68)
Postmarket research (906)
Preclinical (6739)
Press Release (56)
Prostate cancer (219)
Psychedelics (17)
Radiopharmaceuticals (199)
Rare diseases (725)
Real estate (1734)
Recruiting (8)
Regenerative medicine (3)
Regulatory (10475)
Reports (25)
Research institute (1340)
Resumes & cover letters (32)
Rett syndrome (26)
RNA editing (20)
RSV (28)
Schizophrenia (51)
Series A (152)
Series B (105)
Service/supplier (3)
Sickle cell disease (139)
Special edition (9)
Spinal muscular atrophy (108)
Sponsored (26)
Startups (1510)
State (1)
Stomach cancer (17)
Substance use disorders (3)
Supply chain (43)
Tariffs (14)
The Weekly (51)
Vaccines (501)
Venture capital (55)
Weight loss (76)
Women's health (28)
Worklife (2)
Date
Today (70)
Last 7 days (214)
Last 30 days (1018)
Last 365 days (13566)
2026 (9704)
2025 (13617)
2024 (15982)
2023 (17951)
2022 (23932)
2021 (24173)
2020 (20862)
2019 (14473)
2018 (10994)
2017 (12427)
2016 (11241)
2015 (13662)
2014 (9530)
2013 (8045)
2012 (8258)
2011 (8289)
2010 (7358)
Location
Africa (197)
Alabama (24)
Alaska (3)
Arizona (81)
Arkansas (3)
Asia (31643)
Australia (4561)
California (6647)
Canada (1575)
China (1302)
Colorado (176)
Connecticut (197)
Delaware (248)
Europe (41561)
Florida (760)
Georgia (131)
Hawaii (3)
Idaho (19)
Illinois (391)
India (77)
Indiana (135)
Iowa (19)
Japan (526)
Kansas (30)
Kentucky (13)
Louisiana (10)
Maine (65)
Maryland (755)
Massachusetts (5255)
Michigan (77)
Minnesota (195)
Mississippi (1)
Missouri (30)
Montana (9)
Nebraska (9)
Nevada (64)
New Hampshire (12)
New Jersey (1917)
New Mexico (16)
New York (1757)
North Carolina (657)
North Dakota (11)
Northern California (3479)
Ohio (185)
Oklahoma (10)
Oregon (8)
Pennsylvania (1212)
Puerto Rico (6)
Rhode Island (28)
South America (284)
South Carolina (9)
Southern California (2594)
Tennessee (64)
Texas (1244)
United States (22688)
Utah (182)
Vermont (1)
Virginia (178)
Washington D.C. (17)
Washington State (660)
Wisconsin (57)
Wyoming (1)
265,108 Results for "gamida cell ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Manufacturing
BMS ends Cellares pact over cell therapy production problems, triggering layoffs
Setbacks to efforts to use Cellares’ automated platform to make an approved CAR-T cell therapy led BMS to terminate its partnership with the manufacturing specialist.
August 26, 2026
·
2 min read
·
Nick Paul Taylor
Press Releases
Gamida Cell Presents Positive Initial Results on Treating Severe Aplastic Anemia (SAA) with Omidubicel
October 28, 2025
·
3 min read
Press Releases
Visionary Holdings’ Subsidiary Nanjing Tuoyuanjian Health Technology Co., Ltd. Enters into Distribution Agreement with Suncare (Shanghai) Health Technology Co., Ltd.
Collaboration Expected to Expand the Commercialization of Stem Cell Aesthetic and Anti-Aging Products Through an AI-Enabled Community Healthcare and Senior Care Network in China
July 29, 2026
·
4 min read
Press Releases
MUSE Cells Now Available at Longevity Medical Institute®
As part of its Regenerative Neurology Program, Longevity Medical Institute® is making MUSE cell therapy available to select patients, using cells produced in-house at the Institute’s biotechnology laboratory.
September 18, 2026
·
1 min read
Sponsored by Sino Biological
Unlocking cell surface protein research with site-specific labeling
Applications in flow cytometry, cell sorting, target validation, and therapeutic discovery
September 14, 2026
·
8 min read
Press Releases
Femcare Ltd Acquires Orion Medical Supplies Ltd in the UK
August 31, 2026
·
2 min read
Press Releases
Cellares and GenomeFrontier Therapeutics Partner to Evaluate Automated Manufacturing for GF-CART01 on the Cell Shuttle® Platform
September 16, 2026
·
6 min read
Business
Gamida Cell Announces Commencement of Restructuring Process Supported by Highbridge Capital Management
Gamida Cell Ltd., a cell therapy pioneer working to turn cells into powerful therapeutics, announced that it has entered into a Restructuring Support Agreement with certain funds managed by Highbridge Capital Management, LLC, the Company’s principal lender.
March 27, 2024
·
5 min read
Business
Gamida Cell Announces New Leadership Under Ownership of Highbridge Capital Management
Gamida Cell today announced new executive leadership following a successful restructuring transaction (“Transaction”) with certain funds managed by Highbridge Capital Management, LLC (collectively, “Highbridge”) on May 24, 2024.
June 18, 2024
·
4 min read
Genetown
Gamida Cell Actively Pursuing Strategic Alternatives - Jan 29, 2024
Gamida Cell Ltd., a cell therapy pioneer working to turn cells into powerful therapeutics, announced it is actively pursuing strategic alternatives in order to maximize value for all stakeholders, focusing on an asset sale, merger or other strategic transaction.
January 29, 2024
·
2 min read
1 of 26,511
Next
